Cargando…
Diffuse Large B-Cell Lymphoma: Clinical Presentation and Treatment Outcomes From the OncoCollect Lymphoma Registry
BACKGROUND: Diffuse large B-cell lymphoma (DLBCL) is the commonest subtype of lymphoma, standard CHOP was the treatment of choice, 42% of patients received rituximab, and 29% of patients were lost to follow-up during therapy, were reported in a study that collected retrospective data at 13 public an...
Autores principales: | Nair, Reena, Bhurani, Dinesh, Rajappa, Senthil, Kapadia, Asha, Reddy Boya, Rakesh, Sundaram, Subramanian, Menon, Hari, Raman, Ganapathi S., Seshachalam, Arun, Nimmagadda, Ramesh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8847307/ https://www.ncbi.nlm.nih.gov/pubmed/35186714 http://dx.doi.org/10.3389/fonc.2021.796962 |
Ejemplares similares
-
Real-World Outcomes of Hodgkin Lymphoma: A Multi-Centric Registry From India
por: Bhurani, Dinesh, et al.
Publicado: (2022) -
Histopathological pattern of lymphomas and clinical presentation and outcomes of diffuse large B cell lymphoma: A multicenter registry based study from India
por: Nimmagadda, Ramesh B. V., et al.
Publicado: (2013) -
Chemotherapy and echocardiographic indices in patients with non-Hodgkin lymphoma: the ONCO-ECHO study
por: Mizia-Stec, Katarzyna, et al.
Publicado: (2017) -
Indian Council of Medical Research Consensus Document for the Management of Non-Hodgkin's Lymphoma (High Grade)
por: Doval, Dinesh Chandra, et al.
Publicado: (2017) -
Clinical and Epidemiological Profile of Elderly Hodgkin’s Lymphoma in India
por: Sharma, Manish, et al.
Publicado: (2022)